113 related articles for article (PubMed ID: 5214691)
21. Secondary antibody deficiency syndrome in haemoblastosis.
Patakfalvi A
Ann Immunol Hung; 1972; 16(0):309-18. PubMed ID: 4213369
[No Abstract] [Full Text] [Related]
22. Leukocyte function in patients with leukemia.
Rosner F; Valmont I; Kozinn PJ; Caroline L
Cancer; 1970 Apr; 25(4):835-42. PubMed ID: 5266560
[No Abstract] [Full Text] [Related]
23. Immune complexes in myeloproliferative disorders.
Lewis CM; Pegrum GD
Lancet; 1977 Dec; 2(8049):1151-3. PubMed ID: 73061
[TBL] [Abstract][Full Text] [Related]
24. [Bactericidal properties of blood serum and phagocytosis in chronic leukemia].
Ezerskaia MA
Lab Delo; 1967; 7():393-5. PubMed ID: 4178064
[No Abstract] [Full Text] [Related]
25. ENHANCED RETICULOENDOTHELIAL PHAGOCYTIC ACTIVITY IN MYELOPROLIFERATIVE DISEASES.
BASES RE; KRAKOFF IH
J Reticuloendothel Soc; 1965 May; 2():1-7. PubMed ID: 14328081
[No Abstract] [Full Text] [Related]
26. The local inflammatory response in leukocyte disorders.
Bambara LM; Celebrano R; Corrocher R; De Sandre G
Haematologica; 1979 Aug; 64(4):403-15. PubMed ID: 121576
[No Abstract] [Full Text] [Related]
27. Biochemical studies with 1 beta-D-arabinofuranosylcytosine in human leukemic leukocytes and normal bone marrow cells.
Creasey WA; DeConti RC; Kaplan SR
Cancer Res; 1968 Jun; 28(6):1074-81. PubMed ID: 5241767
[No Abstract] [Full Text] [Related]
28. [Morphometric analysis of thrombocyte ultrastructure in healthy persons and in patients with acute leukemia, chronic myeloleukosis and myelofibrosis].
Vashkinel' VK; Petrov MN
Probl Gematol Pereliv Krovi; 1981 Apr; 26(4):30-3. PubMed ID: 6940116
[No Abstract] [Full Text] [Related]
29. [Therapy of chronic leukemias by leukophoresis using cell separator].
Stacher A; Höcker P; Gobets MA
Verh Dtsch Ges Inn Med; 1973; 79():527-30. PubMed ID: 4524466
[No Abstract] [Full Text] [Related]
30. The metabolic and phagocytic activities of leukocytes from children with acute leukemia.
Strauss RR; Paul BB; Jacobs AA; Simmons C; Sbarra AJ
Cancer Res; 1970 Feb; 30(2):480-8. PubMed ID: 4917980
[No Abstract] [Full Text] [Related]
31. The metabolic and phagocytic activities of leukocytes from children with acute leukemia.
Strauss RR; Paul BB; Jacobs AA; Simmons C; Sbarra AJ
Cancer Res; 1970 Feb; 30(2):80-8. PubMed ID: 4909631
[No Abstract] [Full Text] [Related]
32. Results of treatment of leukaemias at the oncological institute in Brno during the period 1935-1960.
Konecný M; Kolár V; Malír A
Neoplasma; 1967; 14(2):207-13. PubMed ID: 5230979
[No Abstract] [Full Text] [Related]
33. Myeloproliferative diseases in childhood.
Nix WL; Fernbach DJ
Am J Pediatr Hematol Oncol; 1981; 3(4):397-407. PubMed ID: 6174053
[TBL] [Abstract][Full Text] [Related]
34. Modulation of natural killer cell-mediated cytotoxicity by partially purified and cloned interferon-alpha.
Lotzová E; Savary CA; Gutterman JU; Hersh EM
Cancer Res; 1982 Jun; 42(6):2480-8. PubMed ID: 6176319
[No Abstract] [Full Text] [Related]
35. [The determination of myeloid-committed stem cells in systemic disorders of myelopoiesis: implications for physiopathology, diagnosis and prognosis].
Hinterberger W
Acta Med Austriaca Suppl; 1981; 21():1-20. PubMed ID: 6949436
[TBL] [Abstract][Full Text] [Related]
36. [Phagocytosis of immune complexes. Its diagnostic and pathological role in idiopathic myelofibrosis (author's transl)].
Ester A; Feliu E; Aguilar JL; Jou JM; Martí M; Marín P; Brugués RM; Vives Corrons JL; Rozman C
Sangre (Barc); 1981; 26(5-A):567-74. PubMed ID: 7323914
[No Abstract] [Full Text] [Related]
37. Cytogenetic studies in the chronic myeloproliferative syndrome.
Kiossoglou KA; Mitus WJ; Dameshek W
Blood; 1966 Aug; 28(2):241-52. PubMed ID: 5222584
[No Abstract] [Full Text] [Related]
38. [Immunoglobulin levels and complement system activity in leukemia].
Kiersnowska-Rogowska B; Pietruska Z; Hryszko S; Bielawiec M
Pol Tyg Lek; 1981 Feb; 36(6):213-6. PubMed ID: 6945567
[No Abstract] [Full Text] [Related]
39. Leukocyte functions study during the treatment of acute lymphoblastic leukemia (ALL).
Pisarek J; Bogusławska-Jaworska J
Arch Immunol Ther Exp (Warsz); 1981; 29(6):711-8. PubMed ID: 6758724
[TBL] [Abstract][Full Text] [Related]
40. THE ROLE OF THE PHAGOCYTE IN HOST-PARASITE INTERACTIONS. I. THE PHAGOCYTIC CAPABILITIES OF LEUKOCYTES FROM LYMPHOPROLIFERATIVE DISORDERS.
SBARRA AJ; SHIRLEY W; SELVARAJ RJ; IOUCHI E; ROSENBAUM E
Cancer Res; 1964 Dec; 24():1958-68. PubMed ID: 14247508
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
